# Azelastine

## Azetin Nasal Spray 140 mcg/dose

| TAH Drug Code      | [**EAZET**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EAZET)                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Allergic rhinitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Dosing             | Seasonal allergic rhinitis: Intranasal One or two sprays in each nostril twice daily                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Hypersensitivity to any ingredients of Azelastine                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Disorder of taste (Adults and adolescents, 4% to 19.7%; pediatrics, 2% to 4% or more ), Vomiting (Pediatrics, 2% or more ), Headache, Somnolence, Epistaxis (Adults and adolescents, 1% to 3.2% ; pediatrics, 2% to 5% or more ), Nasal irritation (less than 1% to 4% ), Pain of nose (Adults and adolescents, 1% to 4%; pediatrics, less than 1% to 4% or more ), Sneezing (Adults and adolescents, 1% to 3.1% ; pediatrics, 2% to 3% or more ), Fatigue (Nasal, less than 1% to 2.3% ; ophthalmic, 1% to 10% ) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

